Is antimullerian hormone (AMH) predictive of reproductive potential in patients with recurrent pregnancy loss (RPL)?

Recurrent pregnancy loss (RPL) is defined as the miscarriage of 2 or more clinical pregnancies. The majority of cases remain unexplained after standard evaluations for anti-phospholipid antibody syndrome (APAS), uterine anomalies and parental karyotypes. While ovarian reserve testing is recommended for women with infertility, the role of ovarian reserve testing in the setting of RPL is unknown.

Source: Fertility and Sterility - March 1, 2018 Category: Reproduction Medicine Authors: Gayathree Murugappan, Lora Shahine, Ruth B. Lathi Tags: Poster presentation Source Type: research